Swedbank Ab Castle Biosciences Inc Transaction History

Swedbank Ab

  • $77.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Dec 09, 2024
SELL
$16.0 - $45.99 $560,000 - $1.61 Million
-35,000 Closed
0 $0
Q3 2021

Dec 09, 2024
SELL
$60.13 - $77.6 $300,650 - $388,000
-5,000 Reduced 12.5%
35,000 $2.33 Million
Q2 2021

Dec 09, 2024
BUY
$50.07 - $76.78 $250,350 - $383,900
5,000 Added 14.29%
40,000 $2.93 Million
Q1 2021

Dec 09, 2024
BUY
$58.92 - $97.33 $2.06 Million - $3.41 Million
35,000 New
35,000 $2.4 Million

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $775M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email